Select Publications

Journal articles

Han M; Pang B; Zhou C; Li X; Wang Q; Jiang J; Li Y, 2022, 'Liquid biopsy of extracellular vesicle biomarkers for prostate cancer personalized treatment decision', Extracellular Vesicles and Circulating Nucleic Acids, http://dx.doi.org/10.20517/evcna.2021.20

Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y, 2021, 'THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer', Advanced Science, vol. 8, pp. 2102658 - 2102658, http://dx.doi.org/10.1002/advs.202102658

Li J; Gao N; Gao Z; Liu W; Pang B; Dong X; Li Y; Fan T, 2021, 'The Emerging Role of Exosomes in Cancer Chemoresistance', Frontiers in Cell and Developmental Biology, vol. 9, pp. 737962, http://dx.doi.org/10.3389/fcell.2021.737962

Dong H; Xie C; Jiang Y; Li K; Lin Y; Pang X; Xiong X; Zheng J; Ke X; Chen Y; Li Y; Zhang H, 2021, 'Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration', Frontiers in Cell and Developmental Biology, vol. 9, http://dx.doi.org/10.3389/fcell.2021.703537

Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y, 2021, 'Activation of the eIF2 alpha/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', REDOX BIOLOGY, vol. 43, http://dx.doi.org/10.1016/j.redox.2021.101993

Gao Z; Pang B; Li J; Gao N; Fan T; Li Y, 2021, 'Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis', Frontiers in Cell and Developmental Biology, vol. 9, http://dx.doi.org/10.3389/fcell.2021.679527

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?', Cancer Letters, vol. 497, pp. 100 - 111, http://dx.doi.org/10.1016/j.canlet.2020.10.016

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance', Journal of the National Cancer Center, vol. 1, pp. 75 - 87, http://dx.doi.org/10.1016/j.jncc.2021.06.001

Gao N; Li Y; Li J; Gao Z; Yang Z; Li Y; Liu H; Fan T, 2020, 'Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers', Frontiers in Oncology, vol. 10, http://dx.doi.org/10.3389/fonc.2020.598817

Dong X; Bai X; Ni J; Zhang H; Duan W; Graham P; Li Y, 2020, 'Exosomes and breast cancer drug resistance', Cell Death and Disease, vol. 11, http://dx.doi.org/10.1038/s41419-020-03189-z

Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y, 2020, 'A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications', Frontiers in Immunology, vol. 11, http://dx.doi.org/10.3389/fimmu.2020.01612

Tran PHL; Xiang D; Tran TTD; Yin W; Zhang Y; Kong L; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Duan W, 2020, 'Exosomes and Nanoengineering: A Match Made for Precision Therapeutics', Advanced Materials, vol. 32, http://dx.doi.org/10.1002/adma.201904040

Ni J; Cheung BB; Beretov J; Duan W; Bucci J; Malouf D; Graham P; Li Y, 2020, 'CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo', Experimental Cell Research, vol. 388, pp. 111850 - 111850, http://dx.doi.org/10.1016/j.yexcr.2020.111850

Tran PHL; Xiang D; Nguyen TNG; Tran TTD; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W, 2020, 'Aptamer-guided extracellular vesicle theranostics in oncology', Theranostics, vol. 10, pp. 3849 - 3866, http://dx.doi.org/10.7150/thno.39706

Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y, 2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, vol. 145, pp. 102860 - 102860, http://dx.doi.org/10.1016/j.critrevonc.2019.102860

Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, vol. 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486

Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, vol. 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106

Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y, 2019, 'Cancer stem cells in prostate cancer radioresistance', Cancer Letters, vol. 465, pp. 94 - 104, http://dx.doi.org/10.1016/j.canlet.2019.08.020

Ni J; Bucci J; Malouf D; Knox M; Graham P; Li Y, 2019, 'Exosomes in Cancer Radioresistance', Frontiers in Oncology, vol. 9, http://dx.doi.org/10.3389/fonc.2019.00869

Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y, 2019, 'Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression', BMC Cancer, vol. 19, http://dx.doi.org/10.1186/s12885-019-5824-9

Wang T; Yin W; AlShamaileh H; Zhang Y; Tran PHL; Nguyen TNG; Li Y; Chen K; Sun M; Hou Y; Zhang W; Zhao Q; Chen C; Zhang PZ; Duan W, 2019, 'A Detailed Protein-SELEX Protocol Allowing Visual Assessments of Individual Steps for a High Success Rate', Human Gene Therapy Methods, vol. 30, pp. 1 - 16, http://dx.doi.org/10.1089/hgtb.2018.237

Feng X; Bai X; Ni J; Wasinger VC; Beretov J; Zhu Y; Graham P; Li Y, 2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, vol. 9, http://dx.doi.org/10.3389/fonc.2019.00557

Ni J; Bongers A; Chamoli U; Bucci J; Graham P; Li Y, 2019, 'In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer', Cancer Control, vol. 26, pp. 1073274819846590, http://dx.doi.org/10.1177/1073274819846590

Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y, 2019, 'Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression', Theranostics, vol. 9, pp. 4130 - 4140, http://dx.doi.org/10.7150/thno.34692

Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y, 2018, 'Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo', BMC Cancer, vol. 18, pp. 1092, http://dx.doi.org/10.1186/s12885-018-5010-5

Bai X; Ni J; Beretov J; Graham P; Li Y, 2018, 'Cancer stem cell in breast cancer therapeutic resistance', Cancer Treatment Reviews, vol. 69, pp. 152 - 163, http://dx.doi.org/10.1016/j.ctrv.2018.07.004

Alshamaileh H; Wang T; Xiang D; Yin W; Tran PHL; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; Shigdar S; Duan W, 2017, 'Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-05859-z

Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y, 2017, 'Urinary biomarkers in prostate cancer detection and monitoring progression', Critical Reviews in Oncology/Hematology, vol. 118, pp. 15 - 26, http://dx.doi.org/10.1016/j.critrevonc.2017.08.002

Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y, 2017, 'Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/srep41834

Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y, 2017, 'Targeting microRNAs in prostate cancer radiotherapy', Theranostics, vol. 7, pp. 3243 - 3259, http://dx.doi.org/10.7150/thno.19934

Xiang D; Shigdar S; Bean AG; Bruce M; Yang W; Mathesh M; Wang T; Yin W; Tran PHL; Shamaileh HA; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; He A; Duan W, 2017, 'Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery', Theranostics, vol. 7, http://dx.doi.org/10.7150/thno.20168

Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y, 2016, 'Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy', Expert Review of Proteomics, vol. 13, pp. 905 - 915, http://dx.doi.org/10.1080/14789450.2016.1233065

Ni J; Cozzi P; Hung T; Hao J; Graham PH; Li Y, 2016, 'Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique', Translational Oncology, vol. 9, pp. 41 - 45, http://dx.doi.org/10.1016/j.tranon.2015.11.011

You J; Willcox M; Fitzgerald A; Schiller B; Cozzi PJ; Russell PJ; Walsh BJ; Wasinger VC; Graham PH; Li Y, 2016, 'Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling', Analytical Biochemistry, vol. 496, pp. 30 - 34, http://dx.doi.org/10.1016/j.ab.2015.12.006

Chang L; Graham P; Hao J; Ni J; Deng J; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Cancer stem cells and signaling pathways in radioresistance', Oncotarget, vol. 7, pp. 11002 - 11017, http://dx.doi.org/10.18632/oncotarget.6760

Hao J; Graham P; Chang L; Ni J; Wasinger V; Beretov J; Deng J; Duan W; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy', Oncotarget, vol. 7, pp. 74269 - 74285, http://dx.doi.org/10.18632/oncotarget.12368

Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y, 2016, 'Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer', Oncotarget, vol. 7, pp. 55771 - 55788, http://dx.doi.org/10.18632/oncotarget.9908

Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y, 2016, 'Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer', Oncotarget, vol. 7, pp. 55518 - 55528, http://dx.doi.org/10.18632/oncotarget.10833

Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y, 2015, 'Proteomics discovery of radioresistant cancer biomarkers for radiotherapy', Cancer Letters, vol. 369, pp. 289 - 297, http://dx.doi.org/10.1016/j.canlet.2015.09.013

Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y, 2015, 'Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance', Critical Reviews in Oncology/Hematology, vol. 96, pp. 507 - 517, http://dx.doi.org/10.1016/j.critrevonc.2015.07.005

Beretov J; Wasinger VC; Millar EKA; Schwartz P; Graham PH; Li Y, 2015, 'Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0141876

Xiang D; Shigdar S; Qiao G; Zhou SF; Li Y; Wei MQ; Qiao L; Al Shamaileh H; Zhu Y; Zheng C; Pu C; Duan W, 2015, 'Aptamer-mediated cancer gene therapy', Current Gene Therapy, vol. 15, pp. 109 - 119, http://dx.doi.org/10.2174/1566523214666141224095105

Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Al Shamaileh H; Yin W; Zhou SF; Zhao X; Duan W, 2015, 'Cancer stem cell targeted therapy: Progress amid controversies', Oncotarget, vol. 6, pp. 44191 - 44206, http://dx.doi.org/10.18632/oncotarget.6176

Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W, 2015, 'Nucleic acid aptamer-guided cancer therapeutics and diagnostics: The next generation of cancer medicine', Theranostics, vol. 5, pp. 23 - 42, http://dx.doi.org/10.7150/thno.10202

Xiang D; Zheng C; Zhou SF; Qiao S; Tran PHL; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W, 2015, 'Superior performance of aptamer in tumor penetration over antibody: Implication of aptamer-based theranostics in solid tumors', Theranostics, vol. 5, pp. 1083 - 1097, http://dx.doi.org/10.7150/thno.11711

Lei C; Wasinger V; Graham P; Hao J; Ni J; Beretov J; Bucci J; Cozzi P; Kearsley J; Li Y, 2014, 'THE USE OF LABEL-FREE LC-MS/MS APPROACH TO IDENTIFY SIGNALING PATHWAYS ASSOCIATED WITH PROSTATE CANCER RADIORESISTANCE', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 10, pp. 130 - 130, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shigdar S; O'Connor M; Lin J; Wang T; Xiang D; Duan W; Li Y; Bhattacharya S; Pu C; Kong L; Wei MQ; Zhu Y; Zhou S, 2014, 'Inflammation and cancer stem cells', Cancer Letters, vol. 345, pp. 271 - 278, http://dx.doi.org/10.1016/j.canlet.2013.07.031

Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W, 2014, 'Inflammation and cancer stem cells', Cancer Letters, vol. 345, pp. 271 - 278, http://dx.doi.org/10.1016/j.canlet.2013.07.031

O'Connor ML; Xiang D; Shigdar S; Macdonald J; Li Y; Wang T; Pu C; Wang Z; Qiao L; Duan W, 2014, 'Cancer stem cells: A contentious hypothesis now moving forward', Cancer Letters, vol. 344, pp. 180 - 187, http://dx.doi.org/10.1016/j.canlet.2013.11.012

Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y, 2014, 'Cancer stem cells in prostate cancer chemoresistance', Current Cancer Drug Targets, vol. 14, pp. 225 - 240, http://dx.doi.org/10.2174/1568009614666140328152459


Back to profile page